The 12th Annual BIO CEO & Investor Conference

Request a Presentation Slot

The aim of the 12th Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies and top public and private equity investors to foster the development of important new medicines that will expand the industry’s pipeline. Companies interested in presenting must focus on biotechnology therapeutics. With this mission, companies exclusively developing medical devices, platform technologies, or diagnostics will not be considered. Companies that meet the stated criteria should FULLY complete the application form below.

All of the information provided below will be used for selection purposes only and will not be printed in conference handbooks or as profiles for the partnering system.

Company Information

Name of Company:

Address1:

Address2:

City:

State:

Postal Code:

Country:

Web Address:

Pipeline Web Address:

Primary Contact Name:

Primary Contact Title:

Primary Contact Email:

Direct Phone:

Ownership:

Presentation Objective:
(2,000 Characters or less)

Company Background:

Year of Incorporation:

Therapeutic Area(s) of Focus:

Company Description/Mission Statement:
(2,000 characters or less)

Technology and Current Research:
(2,000 characters or less):

Partnership Strategy and/or Current Alliances:
(2,000 characters or less):

Recent Milestones:
(250 characters or less):

Anticipated Milestones:
(250 characters or less):

Company Management

Chief Executive Officer and Top Company Official:

        Name:

        Title:

Other Senior Officers:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

Scientific Advisory Board:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

        Name:

        Title:

Financing History

For Private Companies

Most Recent Round of Funding Completed:

Total Amount Raised to Date, in all rounds:

Previous and Current Investors:
(List of up to 10)

For Public Companies

Market Cap:

Market Cap Date:

Exchange:

Ticker:

Additional Information:

(2,000 characters or less)

Company Information
Name of Company:
Address1:
Address2:
City:
State:
Postal Code:
Country:
Web Address:
Pipeline Web Address:
Primary Contact Name:
Primary Contact Title:
Primary Contact Email:
Direct Phone:
Ownership:
Presentation Objective: (2,000 Characters or less)
Company Background:
Year of Incorporation:
Therapeutic Area(s) of Focus:
Company Description/Mission Statement: (2,000 characters or less)
Technology and Current Research: (2,000 characters or less):
Partnership Strategy and/or Current Alliances: (2,000 characters or less):
Recent Milestones: (250 characters or less):
Anticipated Milestones: (250 characters or less):
Company Management
Chief Executive Officer and Top Company Official:
Name:
Title:
Other Senior Officers:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Scientific Advisory Board:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Financing History
For Private Companies
Most Recent Round of Funding Completed:
Total Amount Raised to Date, in all rounds:
Previous and Current Investors: (List of up to 10)
For Public Companies
Market Cap:
Market Cap Date:
Exchange:
Ticker:
Additional Information:
(2,000 characters or less)